Intimation of the outcome of the Board meeting dated May 13, 2026 for approval of the Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Deloitte Haskins & Sells issued an unmodified (clean) audit opinion on the financial statements. The company also announced appointment of B S R & Co LLP as the new statutory auditor for a 5-year term from the 19th AGM, replacing Deloitte Haskins & Sells whose term is ending. The consolidated results include 7 entities including the parent company and its subsidiaries (including those in Singapore). Subsidiary financials show total assets of Rs. 4,685.54 million, full-year revenues of Rs. 1,192.89 million, and net profit after tax of Rs. 53.73 million for the year.
Clean audit opinion indicates no material concerns in financial reporting. The auditor change to B S R & Co LLP (a large firm with pharma sector experience) represents a routine transition following completion of Deloitte's term. Detailed revenue and profit figures for the parent company are not disclosed in this filing.